A global investment case for hepatitis B elimination: a modelling study.

Seaman, Christopher P; Luong, Phillip; Xiao, Yinzong; Abeysuriya, Romesh; Howell, Jess; Hellard, Margaret; Scott, Nick

Seaman, Christopher P; Luong, Phillip; Xiao, Yinzong; Abeysuriya, Romesh; Howell, Jess; Hellard, Margaret; Scott, Nick.

Affiliation

Seaman CP; Burnet Institute, Melbourne, VIC, Australia; School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
Luong P; Burnet Institute, Melbourne, VIC, Australia.
Xiao Y; Burnet Institute, Melbourne, VIC, Australia.
Abeysuriya R; Burnet Institute, Melbourne, VIC, Australia.
Howell J; Burnet Institute, Melbourne, VIC, Australia; School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia; Department of Gastroenterology, St Vincent's Hospital, Melbourne, VIC, Australia; Department of Medicine, University of Melbourne, VIC, Australia.
Hellard M; Burnet Institute, Melbourne, VIC, Australia; School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia; Doherty Institute and School of Population and Global Health, University of Melbourne, VIC, Australia; Department of Infectious Diseases, The Alfred Hospital, M
Scott N; Burnet Institute, Melbourne, VIC, Australia; School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia. Electronic address: nick.scott@burnet.edu.au.

Lancet Gastroenterol Hepatol ; 8(10): 932-942, 2023 10.

Article in En | MEDLINE | ID: mdl-37517417

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Health Care Costs / Hepatitis B Type of study: Prognostic_studies Aspects: Patient_preference Limits: Humans Language: En Journal: Lancet Gastroenterol Hepatol Year: 2023 Document type: Article Affiliation country: Australia Country of publication: Países Bajos

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google